“…MNC preparations contain mainly different stages of progenitor cells and true HSCs and MSCs are rare in these autografts. Smaller studies established the safety of this approach and demonstrated functional and metabolic regeneration of myocardial tissue (Strauer et al, 2005), improvement of vascular function (Erbs et al, 2005), global left ventricular performance (Stamm et al, 2003;Fernandez-Aviles et al, 2004), and peripheral vascular disease (TateishiYuyama et al, 2002). Based on these promising results, larger randomized multicenter trials were conducted.…”